NEW: Parataxis Korea has entered into a definitive agreement with biotech firm Bridge Biotherapeutics to establish a "Bitcoin-native treasury platform" in South Korea's public markets.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
NEW: Parataxis Korea has entered into a definitive agreement with biotech firm Bridge Biotherapeutics to establish a "Bitcoin-native treasury platform" in South Korea's public markets.